logo

BYD’s luxury car brand Yangwang launches Altior electric car in Abu Dhabi

Chinese BYD’s luxury car brand Yangwang has unveiled the all-electric Altior model at a world premiere in Abu Dhabi. Altior is 5.6 metres long and has a four-seat coupé. The model is based on BYD’s e4 platform with four individually controlled electric motors that adjust the torque to each wheel more than 100 times per […]

Svolders’ NAV fell SEK 1 to SEK 62 last week

Investment company Svolders’ NAV decreased by SEK 1 during the past week to SEK 62 per share. Since the start of the year, NAV including reinvested dividends has increased 8 percent, compared with 5 percent for the small-cap index CSRX. In 2025, NAV increased 11 percent compared with 2 percent for the index. The latest […]

Akobo Minerals produced 12 kilos of gold in October – resumes exploration drilling

Gold producer Akobo Minerals produced approximately 12 kilos of doré gold at the Segele mine in Ethiopia during October, with an average processed gold grade of 11 grams per tonne. Total production since operations began thus amounts to approximately 181 kilos, with an average grade of 22 grams per tonne. The lower gold grade in […]

Skanska invests SEK 230 million in housing project in Helsinki

Construction company Skanska is investing EUR 21 million, corresponding to approximately SEK 230 million, in a housing project with 50 apartments in Helsinki, Finland. The project will achieve the highest energy rating and aims for the YL environmental classification. Parts of the roof will be designed as a green roof. Construction is scheduled to start […]

Cantargia selects IL-17 as target for CAN14

The biotechnology company Cantargia has selected IL-17 as the second biological target for the bispecific antibody CAN14. The drug candidate, which is in preclinical development, is designed to simultaneously inhibit IL1RAP and IL-17 signaling. The aim is to improve the treatment of chronic inflammatory diseases by targeting multiple inflammatory signaling pathways at the same time. […]

Nordea initiates coverage of Biogaia with Buy rating – price target of SEK 140

Nordea initiates coverage of probiotic company Biogaia with a Buy rating and a price target of SEK 140, corresponding to a P/E ratio of 29 for 2027. The bank sees support for continued double-digit growth through increased pricing and new premium products. Nordea expects annual revenue growth of 13 percent during 2025–2030, clearly above consensus, […]

Double Bond decides on SEK 10.2 million rights issue

The pharmaceutical company Double Bond Pharma has decided on a rights issue of approximately SEK 10.2 million before issue costs. The issue is covered to approximately 45.1 percent by subscription undertakings from, among others, two major shareholders. The subscription price is SEK 0.11 per share, and twelve existing shares entitle the holder to subscribe for […]

Verifierad av MonsterInsights